These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human apolipoprotein C-III - a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins. Yao Z. Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):133-40. PubMed ID: 23030451 [Abstract] [Full Text] [Related]
10. Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice. Liu YZ, Cheng X, Zhang T, Lee S, Yamauchi J, Xiao X, Gittes G, Qu S, Jiang CL, Dong HH. J Biol Chem; 2016 Jul 08; 291(28):14695-705. PubMed ID: 27226540 [Abstract] [Full Text] [Related]
11. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice. Qu S, Perdomo G, Su D, D'Souza FM, Shachter NS, Dong HH. J Lipid Res; 2007 Jul 08; 48(7):1476-87. PubMed ID: 17438339 [Abstract] [Full Text] [Related]
12. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. Kypreos KE. Biochemistry; 2008 Sep 30; 47(39):10491-502. PubMed ID: 18767813 [Abstract] [Full Text] [Related]
13. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice. Aalto-Setälä K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL. J Lipid Res; 1996 Aug 30; 37(8):1802-11. PubMed ID: 8864964 [Abstract] [Full Text] [Related]
15. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size. Breyer ED, Le NA, Li X, Martinson D, Brown WV. J Lipid Res; 1999 Oct 30; 40(10):1875-82. PubMed ID: 10508207 [Abstract] [Full Text] [Related]
16. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL. J Clin Invest; 1993 Sep 30; 92(3):1143-52. PubMed ID: 8376576 [Abstract] [Full Text] [Related]
17. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Shachter NS. Curr Opin Lipidol; 2001 Jun 30; 12(3):297-304. PubMed ID: 11353333 [Abstract] [Full Text] [Related]
18. APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia. Schmitz J, Gouni-Berthold I. Curr Med Chem; 2018 Jun 30; 25(13):1567-1576. PubMed ID: 28595549 [Abstract] [Full Text] [Related]